{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:06:04Z","timestamp":1794895564003,"version":"4.9.1"},"reference-count":27,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007364","name":"Fondazione CRT\n              https:\/\/ror.org\/04qb3yt59","doi-asserted-by":"publisher","award":["Richieste Ordinarie 2022\u20141\u00b0 Tornata"],"award-info":[{"award-number":["Richieste Ordinarie 2022\u20141\u00b0 Tornata"]}],"id":[{"id":"10.13039\/100007364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background\/Objectives: Medication-related osteonecrosis of the jaw (MRONJ) is a clinically significant side effect related to antiresorptive therapies, such as denosumab and bisphosphonates. MRONJ may develop following oral surgical procedures or spontaneously. Although the pathophysiological processes underlying MRONJ are not well clarified, infections, commonly occurring after oral surgery, seem to have an important contribution in its development. Consequently, the role of the oral microbiota warrants investigation. This study investigates the possible contribution of the salivary microbiota to the onset of osteonecrosis in subjects treated with zoledronate or denosumab. Methods: Three groups of subjects were analyzed: patients treated with zoledronate or denosumab who had developed MRONJ (cases); those who did not (controls) and healthy subjects. Oral microbioma was evaluated through next-generation sequencing. Results: A total of 55 individuals were enrolled: 16 healthy subjects (29.1%), 21 controls (38.2%), and 18 cases (32.7%). Differences in the abundance of certain bacterial taxa were observed both among the three groups and in pairwise comparisons. Furthermore, a cut-off value of 5.51% for Streptococcus spp. was identified as being associated with the development of MRONJ. Conclusions: For the first time, this preliminary study highlights differences in the salivary microbiota among healthy subjects, controls, and cases, suggesting a potential cut-off value for Streptococcus spp. Despite the limited sample size, these findings provide initial insights. Further studies in larger cohorts are warranted.<\/jats:p>","DOI":"10.3390\/biomedicines14040786","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:20:47Z","timestamp":1774884047000},"page":"786","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Possible Contribution of Oral Microbiota in the Osteonecrosis of the Jaw Induced by Zoledronate or Denosumab: A Preliminary Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9684-3499","authenticated-orcid":false,"given":"Francesco Maria","family":"Erovigni","sequence":"first","affiliation":[{"name":"Presidio Dental School, AOU Citt\u00e0 Della Salute e Della Scienza di Torino, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5395-9501","authenticated-orcid":false,"given":"Alessandra","family":"Manca","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, 10149 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Moscone","sequence":"additional","affiliation":[{"name":"Presidio Dental School, AOU Citt\u00e0 Della Salute e Della Scienza di Torino, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5344-9659","authenticated-orcid":false,"given":"Miriam","family":"Antonucci","sequence":"additional","affiliation":[{"name":"Azienda Sanitaria Locale (ASL) Citt\u00e0 di Torino, Amedeo di Savoia Hospital, 10149 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Ghisetti","sequence":"additional","affiliation":[{"name":"Azienda Sanitaria Locale (ASL) Citt\u00e0 di Torino, Amedeo di Savoia Hospital, 10149 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8253-4351","authenticated-orcid":false,"given":"Giorgia","family":"Menegatti","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, 10149 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2585-9607","authenticated-orcid":false,"given":"Francesco","family":"Chiara","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology San Luigi A.O.U., Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9264-0114","authenticated-orcid":false,"given":"Jacopo","family":"Mula","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, 10149 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0860-280X","authenticated-orcid":false,"given":"Alice","family":"Palermiti","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, 10149 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Fusco","sequence":"additional","affiliation":[{"name":"Oncology Unit, Department of Medicine and Translational Medicine Unit, DAIRI\u2014Department of Integration, Research and Innovation \u201cSS Antonio e Biagio e C.Arrigo\u201d Hospital, Azienda Ospedaliero-Universitaria \u201cSS Antonio e Biagio e C.Arrigo\u201d, 15121 Alessandria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Presidio Dental School, AOU Citt\u00e0 Della Salute e Della Scienza di Torino, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Arduino","sequence":"additional","affiliation":[{"name":"Presidio Dental School, AOU Citt\u00e0 Della Salute e Della Scienza di Torino, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1321-4126","authenticated-orcid":false,"given":"Antonio","family":"D\u2019Avolio","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, 10149 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1977-9694","authenticated-orcid":false,"given":"Jessica","family":"Cusato","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, 10149 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1111\/odi.14887","article-title":"Italian position paper (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ)","volume":"30","author":"Bedogni","year":"2024","journal-title":"Oral Dis."},{"key":"ref_2","unstructured":"SIPMO (2020). Raccomandazioni Clinico-Terapeutiche Sull\u2019ostenecrosi Delle Ossa Mascellari (ONJ) Farmaco-Relata e Sua Prevenzione, SIPMO. Available online: https:\/\/www.sipmo.it\/wp-content\/uploads\/2020\/08\/SICMF-SIPMO-2.0_web-con-cover-2020.pdf."},{"key":"ref_3","first-page":"e71","article-title":"Review and update on drugs related to the development of osteonecrosis of the jaw","volume":"25","author":"Eguia","year":"2019","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.coms.2015.06.001","article-title":"Pathophysiology of Osteonecrosis of the Jaws","volume":"27","author":"Aghaloo","year":"2015","journal-title":"Oral Maxillofac. Surg. Clin. N. Am."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"104467","DOI":"10.1016\/j.jcms.2026.104467","article-title":"The effectiveness of different treatment methods in the treatment and prevention of medication-related osteonecrosis of the jaw: A systematic review and Bayesian network meta-analysis","volume":"54","author":"Zhang","year":"2026","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.6026\/973206300214144","article-title":"Managing medication-related osteonecrosis of jaw: A prospective observational study","volume":"21","author":"Dadarwal","year":"2025","journal-title":"Bioinformation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5125\/jkaoms.2026.52.1.18","article-title":"Clinical characteristics of osteonecrosis of the jaw related to denosumab: A 5-year retrospective cohort study","volume":"52","author":"Cho","year":"2026","journal-title":"J. Korean Assoc. Oral Maxillofac. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.joms.2014.07.045","article-title":"Incongruities in the AAOMS position paper: Medication-related osteonecrosis of the jaw--2014 update","volume":"72","author":"Chang","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.joms.2022.07.149","article-title":"Re: AAOMS Position Paper on Medication-Related Osteonecrosis of the Jaw-2022 Update","volume":"80","author":"Campisi","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/clinem\/dgab888","article-title":"Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS","volume":"107","author":"Anastasilakis","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8768162","DOI":"10.1155\/2016\/8768162","article-title":"Medication-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches","volume":"2016","author":"Lombard","year":"2016","journal-title":"Stem Cells Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00784-009-0300-6","article-title":"Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: A possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings","volume":"14","author":"Hoefert","year":"2009","journal-title":"Clin. Oral Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bone.2009.07.011","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation?","volume":"45","author":"Lesclous","year":"2009","journal-title":"Bone"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00774-014-0566-x","article-title":"Prospective, mono-institutional study of the impact of a systematic prevention program on incidence and outcome of osteonecrosis of the jaw in patients treated with bisphosphonates for bone metastases","volume":"33","author":"Bramati","year":"2014","journal-title":"J. Bone Miner. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.joms.2007.11.035","article-title":"Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy","volume":"66","author":"Sedghizadeh","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1601-0825.2012.01916.x","article-title":"Molecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw","volume":"18","author":"Wei","year":"2012","journal-title":"Oral Dis."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kopra, E., Lahdentausta, L., Pietiainen, M., Buhlin, K., Mantyla, P., Horkko, S., Persson, R., Paju, S., Sinisalo, J., and Salminen, A. (2021). Systemic Antibiotics Influence Periodontal Parameters and Oral Microbiota, But Not Serological Markers. Front. Cell Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.774665"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Li, X., Liu, Y., Yang, X., Li, C., and Song, Z. (2022). The Oral Microbiota: Community Composition, Influencing Factors, Pathogenesis, and Interventions. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.895537"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Kim, H.Y., Jung, Y.S., Park, W., Choi, Y.J., and Kim, J.Y. (2024). Can medication-related osteonecrosis of the jaw be attributed to specific microorganisms through oral microbiota analyses? A preliminary study. BMC Oral Health, 24.","DOI":"10.1186\/s12903-024-03945-z"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ijos.2014.46","article-title":"Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw","volume":"6","author":"Pushalkar","year":"2014","journal-title":"Int. J. Oral Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e0404222","DOI":"10.1128\/spectrum.04042-22","article-title":"Site Specialization of Human Oral Veillonella Species","volume":"11","author":"Giacomini","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Jelin-Uhlig, S., Weigel, M., Ott, B., Imirzalioglu, C., Howaldt, H.P., Bottger, S., and Hain, T. (2024). Bisphosphonate-Related Osteonecrosis of the Jaw and Oral Microbiome: Clinical Risk Factors, Pathophysiology and Treatment Options. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158053"},{"key":"ref_23","unstructured":"Patterson, M.J. (1996). Streptococcus. Medical Microbiology, University of Texas Medical Branch at Galveston. [4th ed.]."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jcms.2009.06.005","article-title":"Bisphosphonate-related osteonecrosis of the jaws: A review of 34 cases and evaluation of risk","volume":"38","author":"Kos","year":"2009","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jcms.2017.01.006","article-title":"Role of microbiological culture and polymerase chain reaction (PCR) of actinomyces in medication-related osteonecrosis of the jaw (MRONJ)","volume":"45","author":"Panya","year":"2017","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"452737","DOI":"10.1155\/2014\/452737","article-title":"Is bisphosphonate-related osteonecrosis of the jaw an infection? A histological and microbiological ten-year summary","volume":"2014","author":"Hinson","year":"2014","journal-title":"Int. J. Dent."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.oooo.2016.11.011","article-title":"Bacterial diversity in medication-related osteonecrosis of the jaw","volume":"123","author":"Hallmer","year":"2017","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/4\/786\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:31:56Z","timestamp":1774884716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/4\/786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["biomedicines14040786"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines14040786","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]}}}